Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR52652
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Kirkpatrick, John; Karanth, Megha; Carlomagno, Teresa. "NMR chemical shift assignment of the IMLV methyl groups of a di-domain of the Tomaymycin non-ribosomal peptide synthetase" Biomol. NMR Assignments 19, 153-164 (2025).
PubMed: 40278976
Assembly members:
entity_1, polymer, 537 residues, 59212.13 Da.
Natural source: Common Name: Streptomyces regensis Taxonomy ID: 68263 Superkingdom: Bacteria Kingdom: not available Genus/species: Streptomyces regensis
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pETM44
Data type | Count |
13C chemical shifts | 226 |
1H chemical shifts | 678 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | BN-BC | 1 |
Entity 1, BN-BC 537 residues - 59212.13 Da.
The first four residues (GPML) in the protein are cloning artifacts. Therefore, the appropriate residue numbering has the first residue (G) designated as residue-number '-3', so that the fifth residue (M) has residue-number '1'.
1 | GLY | PRO | MET | LEU | MET | ASN | SER | PRO | LEU | ARG | ||||
2 | THR | THR | VAL | LEU | ASP | LEU | ALA | ARG | THR | THR | ||||
3 | LEU | GLY | SER | ALA | ASP | LEU | THR | ALA | HIS | GLU | ||||
4 | PRO | LEU | ALA | ASP | ARG | CYS | GLU | HIS | PRO | ALA | ||||
5 | LEU | LEU | ASP | ASP | LEU | ALA | THR | THR | LEU | THR | ||||
6 | ALA | VAL | PHE | ALA | VAL | GLU | ILE | THR | GLY | ALA | ||||
7 | ASP | LEU | ALA | ALA | GLY | ALA | THR | VAL | ALA | ASP | ||||
8 | VAL | ALA | ALA | ARG | MET | ASP | ASP | ARG | ARG | ASP | ||||
9 | ALA | PRO | ARG | ILE | PRO | GLU | LEU | ARG | ALA | GLY | ||||
10 | LEU | ALA | PRO | ARG | ASP | GLY | ARG | ALA | VAL | GLU | ||||
11 | ALA | SER | PHE | GLY | GLN | SER | GLY | ILE | TRP | LEU | ||||
12 | ILE | ASP | GLN | TYR | LEU | PRO | ASN | PRO | ALA | ALA | ||||
13 | TYR | ASN | GLY | PRO | PHE | PHE | VAL | ARG | LEU | PRO | ||||
14 | PHE | SER | ALA | ASP | PRO | ASP | ARG | LEU | HIS | ALA | ||||
15 | ALA | VAL | ARG | GLY | VAL | LEU | ARG | ARG | GLN | GLU | ||||
16 | VAL | LEU | ARG | THR | THR | TYR | ALA | LEU | SER | ASP | ||||
17 | GLY | THR | LEU | ARG | GLN | ASN | VAL | SER | ARG | ASP | ||||
18 | ASP | ASP | ALA | VAL | VAL | PHE | GLU | VAL | ALA | ARG | ||||
19 | TYR | GLY | ASP | ASP | LYS | GLU | LEU | ASP | ALA | LEU | ||||
20 | VAL | HIS | ARG | VAL | ALA | ASN | LEU | ARG | LEU | ASP | ||||
21 | LEU | ALA | ARG | GLY | PRO | VAL | ILE | ALA | VAL | THR | ||||
22 | CYS | ALA | LEU | GLY | PRO | ALA | ASN | ARG | SER | ALA | ||||
23 | VAL | ILE | CYS | ASN | ILE | HIS | HIS | ILE | ALA | SER | ||||
24 | ASP | ALA | ALA | SER | ALA | GLY | VAL | PHE | LEU | ARG | ||||
25 | GLU | LEU | LEU | ASP | ALA | TYR | ASP | ARG | LEU | GLY | ||||
26 | ARG | GLY | LEU | PRO | VAL | GLU | ALA | ASP | PRO | LEU | ||||
27 | ARG | PRO | THR | TYR | GLY | ASP | PHE | SER | GLN | TRP | ||||
28 | TYR | ARG | GLU | LEU | MET | ASN | PRO | GLU | ALA | LEU | ||||
29 | THR | ARG | SER | LEU | ASP | HIS | PHE | ALA | ALA | ARG | ||||
30 | LEU | ALA | GLY | GLU | LEU | PRO | VAL | LEU | ASP | LEU | ||||
31 | PRO | THR | ASP | ARG | PRO | ARG | PRO | PRO | VAL | LYS | ||||
32 | GLN | HIS | ARG | GLY | GLY | THR | LEU | PRO | LEU | HIS | ||||
33 | LEU | PRO | ALA | ALA | ALA | ALA | ASP | ASP | PHE | GLU | ||||
34 | ALA | LEU | ALA | ARG | THR | GLU | GLY | VAL | THR | LEU | ||||
35 | PHE | MET | ALA | LEU | VAL | ALA | ALA | TYR | ALA | VAL | ||||
36 | PHE | LEU | SER | ARG | HIS | THR | GLY | GLN | ARG | ARG | ||||
37 | VAL | LEU | ILE | GLY | SER | PRO | VAL | SER | LEU | ARG | ||||
38 | ASP | ASP | PRO | ALA | THR | HIS | GLU | LEU | ILE | GLY | ||||
39 | TYR | PHE | VAL | ASN | LEU | VAL | VAL | LEU | GLN | GLN | ||||
40 | GLU | ILE | ASP | ASP | ARG | MET | THR | VAL | ARG | ASP | ||||
41 | VAL | LEU | ARG | ARG | ALA | ARG | GLU | GLU | VAL | SER | ||||
42 | GLU | ALA | LEU | ARG | HIS | LYS | TRP | ALA | PRO | PHE | ||||
43 | ASP | LYS | VAL | VAL | GLU | ARG | LEU | GLN | PRO | PRO | ||||
44 | ARG | SER | SER | GLY | TYR | THR | PRO | LEU | VAL | GLN | ||||
45 | THR | MET | LEU | VAL | LEU | THR | GLN | GLY | ASP | ALA | ||||
46 | GLY | ARG | ILE | SER | HIS | ASP | ASP | THR | GLU | LEU | ||||
47 | ARG | ILE | GLU | ARG | GLY | ALA | ALA | HIS | GLY | ALA | ||||
48 | LYS | TYR | ASP | LEU | SER | LEU | VAL | PHE | GLU | ARG | ||||
49 | ASP | SER | GLU | GLY | LEU | HIS | GLY | LEU | ILE | GLU | ||||
50 | TYR | ASP | ALA | ASP | LEU | PHE | ASP | GLU | PRO | THR | ||||
51 | VAL | ARG | ALA | MET | GLY | ASP | ARG | LEU | ARG | HIS | ||||
52 | LEU | MET | GLU | GLN | PHE | ALA | ARG | ARG | PRO | ASP | ||||
53 | ALA | PRO | LEU | HIS | GLU | LEU | GLU | ALA | LEU | GLY | ||||
54 | ALA | GLN | GLU | ARG | ARG | SER | VAL |
sample_1: BN-BC, [U-12C; U-2H; 50% (racemic) 1H,13C-Leu-D1/D2; 50% (racemic) 1H,13C-Val-G1/G2, 550 uM; sodium phosphate 50 mM; sodium chloride 150 mM; TCEP 0.75 mM; EDTA 0.5 mM; sodium azide 0.02%
sample_2: BN-BC, [U-12C; U-2H; 100% 1H,13C-Ile-D1, 100% 1H,13C-Met-E, 50% (racemic) 1H,13C-Leu-D1/D2; 50% (racemic) 1H,13C-Val-G1/G2, 800 uM; sodium phosphate 50 mM; sodium chloride 150 mM; TCEP 0.75 mM; EDTA 0.5 mM; sodium azide 0.02%
sample_3: BN-BC, [U-12C; U-2H; 100% 1H,13C-Ile-D1, 100% 1H,13C-Met-E, 50% (racemic) 1H,13C-Leu-D1/D2; 50% (racemic) 1H,13C-Val-G1/G2, 800 uM; sodium phosphate 50 mM; sodium chloride 150 mM; TCEP 0.75 mM; EDTA 0.5 mM; sodium azide 0.02%
sample_4: BN-BC, [U-12C; U-2H; 100% 1H,13C-Met-E, 100% 1H,13C-Val-G2, 250 uM; sodium phosphate 50 mM; sodium chloride 150 mM; TCEP 0.75 mM; EDTA 0.5 mM; sodium azide 0.02%
sample_5: BN-BC, [U-12C; U-2H; 50% (racemic) 1H,13C-Leu-D1/D2; 50% (racemic) 1H,13C-Val-G1/G2, 100 uM; sodium phosphate 50 mM; sodium chloride 150 mM; TCEP 0.75 mM; EDTA 0.5 mM; sodium azide 0.02%
sample_6: BN-BC, [U-12C; U-2H; 100% 13C-Leu-CB,CG; 50% (racemic) 1H,13C-Leu-D1/D2; 100% 13C-Val-C,CA,CB; 50% (racemic) 1H,13C-Val-CG1/CG2, 100 uM; sodium phosphate 50 mM; sodium chloride 150 mM; TCEP 0.75 mM; EDTA 0.5 mM; sodium azide 0.02%
sample_conditions_1: pH: 7.0; temperature: 298 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-13C HMQC | sample_1 | isotropic | sample_conditions_1 |
2D 1H-13C HMQC | sample_2 | isotropic | sample_conditions_1 |
2D 1H-13C HMQC | sample_3 | isotropic | sample_conditions_1 |
2D 1H-13C HMQC | sample_4 | isotropic | sample_conditions_1 |
2D 1H-13C HMQC | sample_5 | isotropic | sample_conditions_1 |
4D 13C-HMQC-NOESY-13C-HMQC | sample_1 | isotropic | sample_conditions_1 |
4D 13C-HMQC-NOESY-13C-HMQC | sample_2 | isotropic | sample_conditions_1 |
3D (H)CCH 13C-HMQC-NOESY-13C-HMQC | sample_3 | isotropic | sample_conditions_1 |
3D HCH 13C-HMQC-NOESY | sample_3 | isotropic | sample_conditions_1 |
3D HmCmCG/CB | sample_6 | isotropic | sample_conditions_1 |
TOPSPIN v3.2 - collection
NMRPipe - processing
CcpNMR v2.4 - chemical shift assignment, data analysis
istHMS - processing
FuDA - data analysis
PDB |